CNCorey L. Nagel

Corey L. Nagel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Corey L. Nagel has a total of 78 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prevalent physical multimorbidity patterns and depressive symptom trajectories among community dwelling U.S. older adults

    by Nicholas J. Bishop, Kealie J. Walker, Corey L. Nagel, Jason T. Newsom, Anda Botoseneanu, Heather G. Allore, Federico Triolo, Ana R. Quiñones

    Over 35% of older adults experience depression (Cai et al., 2023) and depression is associated with lower quality of life (Sivertsen et al., 2015) and increased risk of mortality and suicidality (F...

  • Open Access

    Potential Mechanisms of Influence Between Spiritual Practices and Cognitive Health: A Systematic Review and Conceptual Model

    by Katherine Carroll Britt, Hayoung Oh, Augustine Cassis Obeng Boateng, Sherry Morgan, Sato Ashida, Corey Nagel, Roland J. Thorpe, Harold G. Koenig

    Background/Objectives: This systematic review summarizes the evidence regarding potential mechanisms underlying the relationship between spiritual practices and cognitive health in adults. The review was performed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. Methods: An extensive search of six electronic databases (i.e., PubMed, PsycINFO, Embase, Sociological Abstracts, ATLA, CINAHL) was conducted using keywords related to spiritual practices, religious activities, and cognitive health from 1 January 2000 to December 2025. The quality of the included studies was assessed using the Mixed Methods Appraisal tool aligned with the study design. Results: A total of 34 studies were selected for final inclusion in this review, and a narrative synthesis is provided. The studies were conducted throughout the world, with most studies conducted in North America and Asia. Short- and medium-term effects of spiritual practices on cognitive health were identified across heterogeneous practices ranging from meditation, tai chi and yoga to general spiritual and religious activities. Across the strongest evidence, 73% of the randomized control trials examined reported better cognitive health among the more spiritually active; neurobiological factors of decreased inflammation and improved immune response helped to explain these effects. A total of 5 studies examined mediators, while 29 studies contained only secondary outcomes for determining potential mechanisms. Informed by findings across psychosocial, behavioral, and neurobiological pathways, a conceptual model was created and needs testing. Conclusions: Possible mechanisms for spiritual effects on cognition may be through mental health and neurobiological factors, although more rigorous and long-term studies are needed.


  • Open Access

    Longitudinal sequencing of cardiometabolic multimorbidity among older adults and association with subsequent dementia onset

    by Corey L. Nagel, Siting Chen, Heather G. Allore, Anda Botoseneanu, Jason T. Newsom, Nick Bishop, David A. Dorr, Jeffrey Kaye, Ana R. Quiñones

    Background: Patterns of development of cardiometabolic multimorbidity (CMM) and the impact of specific cardiometabolic disease combinations on cognitive function are not well understood. This study utilizes sequence analysis to describe the ordering and timing of cardiometabolic disease accumulation over a five-year period and to assess both sociodemographic predictors and cognitive outcomes of typical cardiometabolic disease sequences. Methods: We analyzed data from the National Health and Aging Trends Study (2011–2022), including respondents aged ≥65 years without CMM or cognitive impairment at baseline (N = 4956). We used sequence analysis with optimal matching and hierarchical cluster analysis to describe temporal patterns of cardiometabolic disease accumulation and to construct a typology by clustering similar sequences. Sociodemographic predictors of CMM cluster membership were assessed using multinomial logistic regression and discrete time survival analysis was used to examine the association of CMM clusters with subsequent dementia development. Results: 11.8% of respondents developed CMM within 5-years. From a total of 366 distinct cardiometabolic disease sequences, we identified eight cardiometabolic sequence clusters. The first five clusters, “No Cardiometabolic Disease” (N = 2283, 46.1%); “Diabetes Only” (N=642, 13.0%); Heart Disease Only” (N = 297, 6.0%); “MI Only” (N = 145, 2.9%); “Stroke Only” (N = 132, 2.7%), were composed of persons who did not develop CMM over the observation period. The sixth cluster, “Incident CVD with Multimorbidity” (N = 656, 13.2%), was largely composed of persons with no conditions at baseline who developed incident cardiometabolic disease and/or CMM during the observation period (N = 477, 72.7%) and the seventh cluster, “Diabetes Multimorbidity” (N = 333, 6.7%), primarily consisted of persons with diabetes who developed incident CMM. Finally, the eight cluster (N = 468, 9.4%) was characterized by mortality early in the observation period with minimal CMM development during the observation period. Black and Hispanic race/ethnicity, lower wealth, and obesity were associated with increased likelihood of membership in one or both of the clusters characterized by CMM development. We observed increased dementia risk among persons in the Incident CVD with Multimorbidity cluster (HR = 1.32, 95% CI = 1.04–1.67) and the Diabetes MM cluster (HR = 1.88, 95% CI = 1.44,2.44). Conclusions: Development of cardiometabolic multimorbidity is more likely among minoritized and/or low-income older adults and is associated with increased risk of subsequent dementia. Targeted approaches to cardiometabolic disease prevention and risk reduction may be an effective means of slowing or preventing the onset of cognitive decline among these groups.


  • Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study

    by Joseph Asante, Corey L Nagel, Steven W Barger

    Background: P-glycoprotein (P-gp) is linked to Alzheimer's disease (AD), as P-gp contributes to clearance of amyloid-β (Aβ) from the CNS. Thus, other P-gp substrates (Pgp-S) could affect Aβ clearance, either negatively through competitive inhibition or positively via cooperative transport, impacting risk for AD. Objective: We probed impacts of Pgp-S on AD risk by querying AD rates among individuals prescribed medications that are considered Pgp-S. Methods: A retrospective cohort study was performed using the PharMetrics Plus database (IQVIA), encompassing 70,340 users of prescription drugs identified as Pgp-S and 352,382 Pgp-S non-users. Users and non-users were matched by age, sex, and geographical region. Cox regression models afforded adjustments for covariates and comorbidities. Results: Pgp-S use was generally associated with a significant reduction in the hazard ratio of AD in both crude (HR = 0.89, 95% CI = 0.79–0.99) and matched (HR = 0.87; 95% CI = 0.78–0.98) analyses. AD risk was higher among subsets diagnosed with comorbidities: depression (HR = 4.44; 95% CI, 3.99–4.94), stroke (HR = 1.98, 95% CI = 1.63–2.41), and hypertension (HR = 1.24, 95% CI = 1.13–1.36). In an analysis of individual drugs, digoxin (OR = 0.52, 95% CI, 0.34–0.77), atorvastatin (OR = 0.80, 95% CI, 0.73–0.87), omeprazole (OR = 0.83, 95% CI, 0.73–0.94), and prednisone (OR = 0.64, 95% CI, 0.46–0.86) were associated with significantly decreased odds of incident AD; rivaroxaban (OR = 1.29, 95% CI = 0.97–1.68) and mirabegron (OR = 1.45, 95% CI = 0.86–2.28) trended toward increased risk. Conclusions: The findings suggest an association between Pgp-S use and AD, but limitations of the study design impel additional work to confirm the direction of impact for individual drugs.


  • Open Access

    Multimorbidity patterns and cognitive change among Mexican older adults: findings from the Mexican Health and Aging Study

    by Nicholas J. Bishop, Anda Botoseneanu, Jason T. Newsom, Heather G. Allore, Corey L. Nagel, Sheila Markwardt, Rafael Samper-Ternent, Ana R. Quiñones

    Introduction: Mexico faces unique challenges due to the confluence of population ageing, an increasing burden of chronic conditions and limited resources to address these concerns. Substantial evidence links both independent and co-occurring chronic conditions to the risk of cognitive decline, but the association between common multimorbidity patterns and change in cognitive function has not been examined among older adults in Mexico. Objective: The objective of our research was to identify the most common multimorbidity patterns among ageing Mexican adults in 2012, then examine the association between these multimorbidity patterns and change in cognitive function with advancing age. Methodology: Data from the Mexican Health and Aging Study (2012–21; n = 6,082) was used to identify multimorbidity patterns in 2012 (including hypertension, diabetes, cancer, lung disease, heart attack, stroke, arthritis and depressive symptoms), then latent growth modelling was used to examine associations between the mean cognitive trajectory and the baseline multimorbidity patterns. Results: Several baseline multimorbidity patterns were associated with variation in cognitive function. Diabetes and depressive symptoms were present in the majority of multimorbidity patterns associated with lower cognitive function at baseline, and respondents with either lone diabetes or hypertension+diabetes+arthritis at baseline experienced more rapid cognitive decline than those reporting no conditions at baseline. Conclusion: Our findings suggest that prevention and management of diabetes may reduce cognitive gaps that manifest prior to older adulthood and protect against rapid cognitive decline among older Mexican adults. Further examination of depressive symptoms as a component of multimorbidity and cognitive change is also warranted.


  • Informal Care Receiving Among Older Adults: The Role of Multimorbidity and Intersectional Social Position

    by Ruotong Liu, Corey L Nagel, Siting Chen, Heather G Allore, Ana R Quiñones

    Background and Objectives: Older adults with distinct multimorbidity combinations may require varying intensities of informal care and these needs may vary in important ways by race/ethnicity and sex. This study aims to examine informal care-receiving characteristics among older adults with varying multimorbidity patterns and race/ethnicity-sex characteristics. Research Design and Methods: A total of 4,875 participants from the National Health and Aging Trends Study were included. Five clinically informed multimorbidity categories (no condition(s), somatic-only, depression without cognitive impairment, cognitive impairment without depression, both depression, and cognitive impairment) and 6 intersectional groups (non-Hispanic White female, non-Hispanic White male, non-Hispanic Black female, non-Hispanic Black male, Hispanic female, and Hispanic male) were assessed. Negative binomial regression was applied to explore the associations among multimorbidity groups, race/ethnicity and sex combinations, and informal care-receiving characteristics. Results: Compared with the somatic-only multimorbidity group, individuals with no condition(s) received assistance with fewer ADL/IADL activities, whereas the cognitive impairment multimorbidity group received assistance with more ADL/IADL activities. Across race/ethnicity-sex groups, non-Hispanic White and Black males received assistance with fewer ADL/IADL activities, and no statistical significance was found for non-Hispanic Black females or Hispanics compared with non-Hispanic White female counterparts. Sensitivity analysis examining assistance with only ADL activities revealed the same pattern. Discussion and Implications: The study highlighted the complexities of informal care-receiving characteristics among older adults, particularly among those with cognitive difficulties, and the ways in which race/ethnicity and sex are associated with care-receiving patterns. The findings highlight a need for person- and family-centered interventions sensitive to the diverse needs of care-recipients and caregivers.


  • Cardiometabolic Multimorbidity and Dementia Onset Among Middle-Aged and Older Adults: Differences by Race/Ethnicity

    by Siting Chen, Ana R Quiñones, Corey L Nagel, Nicholas J Bishop, Heather G Allore, Jason T Newsom, Jeffrey Kaye, Anda Botoseneanu

    Background: Racial/ethnic minoritized groups in the United States have a higher prevalence of cardiometabolic multimorbidity and experience a higher risk of dementia. This study evaluates the relationship between cardiometabolic multimorbidity and dementia onset according to racial/ethnic group in a nationally representative cohort of U.S. middle-aged and older adults. Methods: Data from the Health & Retirement Study (1998–2018, N = 7,960, mean baseline age 59.4 years) and discrete-time survival models were used to estimate differences in the risk of dementia onset, defined by Langa–Weir classification. Models included race/ethnicity (non-Hispanic White, non-Hispanic Black, and Hispanic), chronic disease/multimorbidity categories (no disease, one disease, cardiovascular multimorbidity, metabolic multimorbidity, cardiometabolic multimorbidity, other multimorbidity), age, sex, education, wealth, body-mass index, and proxy status. Results: Over a mean follow-up of 14.6 years, 7.7% of the participants (n = 614) developed dementia. In the fully adjusted model, participants with cardiometabolic multimorbidity had the highest risk of dementia onset (HR:3.27, 95%CI: 2.06, 5.21), followed by metabolic (HR:1.83, 95%CI: 1.14, 2.94), and cardiovascular (HR:1.81, 95%CI: 1.24, 2.64) multimorbidity, relative to participants with no disease. The risk of dementia was significantly greater among Black (HR: 6.40, 95% CI: 3.84, 10.67) and Hispanic participants (HR: 4.90, 95% CI: 2.85, 8.43) with cardiometabolic multimorbidity, compared with White adults with no disease. Conclusions: Individuals from racial/ethnic minoritized groups have a higher risk of dementia. The risk of dementia onset was significantly greater for Black and Hispanic participants experiencing cardiometabolic multimorbidity, highlighting the value of intervening in cardiometabolic conditions among middle-aged and older adults, in particular, those from racial/ethnic minoritized backgrounds to reduce the risk of developing dementia.


  • Open Access

    Social Deprivation and Multimorbidity Among Community-Based Health Center Patients in the United States

    by Steele Valenzuela, Katherine D. Peak, Nathalie Huguet, Miguel Marino, Teresa D. Schmidt, Robert Voss, Ana R. Quiñones, Corey Nagel

    Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention.


  • Exploring Perceived Limitations to Daily Activities Due to Chronic Conditions: A Person-Centered Approach to Measuring Multimorbidity Severity

    by Nicholas J Bishop, Corey Nagel, Ana R Quiñones

    Background: Person-centered approaches to measuring severity of multimorbidity (≥ 2 chronic conditions) can help clinicians assess the individual experience of multimorbidity and inform effective caregiving and intervention strategies. We examine how limitations in everyday activities attributable to specific chronic conditions act independently and in tandem to influence individual perceptions of multimorbidity severity. Methods: Data from the Panel Study of Income Dynamics (2005–2021) were used to investigate self-reported limitations in normal daily activities resulting from nine chronic conditions (hypertension, arthritis, diabetes, heart condition [heart disease/heart attack], cancer, lung disease, stroke, depression, and memory loss) in 4 318 adults aged 55–95 (18 878 person-wave observations). We used descriptive and inferential analyses to estimate limitations resulting from specific conditions, limitations attributable to condition combinations, and the contribution of comorbid conditions to condition-specific and overall severity. Follow-up analyses addressed mortality selection using inverse probability weighting and examined cancer type and cancer status/treatment modality among respondents reporting cancer diagnosis. Results: Of the more prevalent conditions, arthritis was associated with the most severe limitations to normal activities. Memory loss was the least frequent condition reported but resulted in the most severe limitations, and as a comorbid condition, increased limitations reported for most conditions. Inverse probability weighting adjusted models revealed heterogeneity in estimates for some conditions including cancer and cancer survivors tended to report less lethal cancers that were cured or in remission. Conclusions: Our results suggest that efforts to prevent and treat arthritis and support cognitive function may reduce the severity of multimorbidity experienced by the individual.


  • Recommendations on Methods for Assessing Multimorbidity Changes Over Time: Aligning the Method to the Purpose

    by Corey L Nagel, Nicholas J Bishop, Anda Botoseneanu, Heather G Allore, Jason T Newsom, David A Dorr, Ana R Quiñones

    Background: The rapidly growing field of multimorbidity research demonstrates that changes in multimorbidity in mid- and late-life have far reaching effects on important person-centered outcomes, such as health-related quality of life. However, there are few organizing frameworks and comparatively little work weighing the merits and limitations of various quantitative methods applied to the longitudinal study of multimorbidity.Methods: We identify and discuss methods aligned to specific research objectives with the goals of (i) establishing a common language for assessing longitudinal changes in multimorbidity, (ii) illuminating gaps in our knowledge regarding multimorbidity progression and critical periods of change, and (iii) informing research to identify groups that experience different rates and divergent etiological pathways of disease progression linked to deterioration in important health-related outcomes.Results: We review practical issues in the measurement of multimorbidity, longitudinal analysis of health-related data, operationalizing change over time, and discuss methods that align with 4 general typologies for research objectives in the longitudinal study of multimorbidity: (i) examine individual change in multimorbidity, (ii) identify subgroups that follow similar trajectories of multimorbidity progression, (iii) understand when, how, and why individuals or groups shift to more advanced stages of multimorbidity, and (iv) examine the coprogression of multimorbidity with key health domains.Conclusions: This work encourages a systematic approach to the quantitative study of change in multimorbidity and provides a valuable resource for researchers working to measure and minimize the deleterious effects of multimorbidity on aging populations.